Drug intelligence / Profile preview

TauroPace

Development stage
Unknown
Lead developer
TauroPharm
Modality
Small Molecules
Administration
Irrigation, Topical
01

Overview

TauroPace is an antimicrobial irrigation solution containing taurolidine, a broad-spectrum, non-antibiotic antiseptic agent designed to prevent infections associated with cardiac implantable electronic devices (CIEDs). Developed by TauroPharm, it is used during surgical procedures to wash external hardware surfaces—such as leads, suture sleeves, and pulse generators—and to irrigate the subcutaneous device pocket. The active ingredient, taurolidine, acts by releasing methylol groups that chemically react with bacterial cell wall components (specifically peptidoglycan and lipopolysaccharides) and neutralize bacterial endotoxins and exotoxins. This mechanism prevents microbial colonization and the formation of bacterial biofilms without the risk of developing antibiotic resistance. TauroPace is CE-marked in Europe as a medical device and is primarily indicated for patients undergoing CIED implantation, revision, or replacement to reduce the risk of major complications such as pocket infections, lead-related endocarditis, and systemic sepsis.

Brand names
TauroPace
Other names
TPTaurolidine containing antimicrobial CIED wash
02

Targets

PGN (Peptidoglycan)

Beyond the preview

Go deeper on TauroPace.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TauroPace.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call